Does dahlia flower extract have anti-diabetic properties?

The effects of an extract of yellow petals of Dahlia pinnata as a novel treatment of type 2 diabetes (T2D).

EMA accepts Alvotech and Advanz Pharma’s AVT05 MAA

This application marks the first global MAA filing for a biosimilar candidate to Simponi for treating chronic inflammatory conditions. Credit: BlurryMe/Shutterstock. The European Medicines Agency

November 5, 2024

Cedar Clinical Research selected as clinical research site for Cybin’s Phase 3 Study of CYB003 | Psychedelic Invest

VANCOUVER, BC, April 17, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health

April 17, 2024

Drugmakers to Maryland affordability board: Capping list prices may not help patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.